Navigation Links
Elsevier Announces New Partnership With Canadian Cardiovascular Society to Publish the Canadian Journal of Cardiology

Elsevier Announces New Partnership With Canadian Cardiovascular Society to Publish the Canadian Journal... -- OTTAWA, November 2, 2010 /PRNewswire-FirstCall/ --

Advanced Search Search

  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biotechnology, Health Care & Hospitals, Medical Pharmaceuticals, Contracts, New Products & Services Click to view news release full screen  

Elsevier Announces New Partnership With Canadian Cardiovascular Society to Publish the Canadian Journal of Cardiology


OTTAWA, November 2, 2010 /PRNewswire-FirstCall/ --

- Journal Under Editorial Leadership of Stanley Nattel, MD, FRSC, FRCPC, FACC, FHRS

Elsevier, a world-leading publisher of scientific, technical, and medical information products and services, is pleased to announce a new partnership with the Canadian Cardiovascular Society and the January 2011 publication of the Canadian Journal of Cardiology, an established journal in the field of cardiovascular medicine.

Under the guidance of Editor-in-Chief Stanley Nattel, MD, FRSC, FRCPC, FACC, FHRS, Paul-David Chair in Cardiovascular Electrophysiology and Professor of Medicine at the University of Montreal and Director of the Electrophysiology Research Program at the Montreal Heart Institute Research Center, and a renowned Editorial Board, this internationally recognized journal publishes peer-review material pertinent to specialists, general practitioners, and cardiovascular scientists and addresses all aspects of cardiovascular medicine.

The Canadian Journal of Cardiology is the official journal of the Canadian Cardiovascular Society. It is a vehicle for the international dissemination of new knowledge in cardiology and cardiovascular science, particularly serving as a major venue for the results of Canadian cardiovascular research and Society guidelines. The Journal publishes original reports of clinical and basic research relevant to cardiovascular medicine as well as editorials, review articles, case reports, and papers on health outcomes, policy research, ethics, medical history, and political issues affecting practice.

"The Canadian Journal of Cardiology has been at the forefront in publishing clinical reports and research relevant to cardiovascular medicine for many years," comments Dr. Nattel, "we are confident that partnering with Elsevier will further our reach and impact in international cardiovascular circles. This is an exciting time for the CJC."

"The Canadian Journal of Cardiology has been and will continue to be the voice of our Society," says CCS President Charles Kerr. The Journal is a key benefit of Society membership. It serves as a vehicle of communication that reinforces the strength of not only the CCS, but the cardiovascular specialty as a whole."

The Canadian Journal of Cardiology will serve as a vehicle to enhance the dissemination of medical knowledge that will benefit people with cardiovascular disease.

About the Editor

Read more about Editor-in-Chief Dr. Stanley Nattel, MD, FRSC, FRCPC, FACC, FHRS, at:



(Due to the length of these URLs, it may be necessary to copy and paste the hyperlink into your Internet browser's URL address field. Remove the space if one exists.)

About The Canadian Cardiovascular Society

The Canadian Cardiovascular Society is the professional association for Canadian cardiovascular physicians and scientists working to promote cardiovascular health and care through knowledge translation, professional development, and leadership in health policy. The CCS provides programs and services to its 1900+ members and others in the cardiovascular community, including guidelines for cardiovascular care, the annual Canadian Cardiovascular Congress, and, with the Canadian Cardiovascular Academy, programs for trainees. More information about the CCS and its activities can be found at

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet ( and Cell (, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect (, SciVerse Scopus (, Reaxys (, MD Consult ( and Nursing Consult (, which enhance the productivity of science and health professionals, and the SciVal suite ( and MEDai's Pinpoint Review (, which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier ( employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC (, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media Contact: Jane Grochowski Publisher, Elsevier +1-406-542-8397

SOURCE Elsevier
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Elsevier Introduces Article-Based Publishing to Increase Publication Speed
2. Elseviers BrainNavigator 3.0 Reflects the Next Step in Enhancing Neurological Research
3. Elsevier Survey Reveals Researchers Ready to Push Scientific Search and Discovery to the Next Level
4. Elsevier Congratulates its British Medical Association (BMA) Award Winning Medical Authors and Editors
5. New Procedures Consult Mobile From Elsevier Enables Clinicians to View Top Medical Procedures From Mobile Devices
6. Twelve Women Scientists Announced as Winners of Elsevier Foundation TWOWS Awards
7. Elsevier Addresses Todays Healthcare Information Crisis With a Renewed Focus on Improving Quality and Efficiency
8. Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers
9. Elseviers BrainNavigator Research Tool to Launch new Features at Neuroscience 2009 Show
10. Elsevier Joins InChI Trust as a Charter Member
11. Elsevier Global Medical News Launches H1N1 Channel
Post Your Comments:
(Date:10/8/2015)... 8, 2015  Today the Wyss Institute for Biologically ... its start-up company Opsonix Inc. The announcement ... Office of Technology Development (OTD) and Opsonix Inc. ... for clinical use. --> ... million people every year in the U.S. — more ...
(Date:10/8/2015)... ... 2015 , ... Talon Innovations, a provider of Precision Machined Products ... it is one of three finalists for the Minnesota Business magazine’s Manufacturing Award in ... Talon Innovations was recognized as a nominee for this competitive award. , The ...
(Date:10/8/2015)... ... October 08, 2015 , ... Cystic ... transmembrane conductance regulator (CFTR) gene and results in dysfunction of the lungs and ... in the lungs. This mucus is very difficult to clear, blocks the airways ...
(Date:10/7/2015)... Boston Scientific (NYSE: BSX ... Boston Scientific Connected Patient Challenge , an open innovation ... remote patient monitoring to enhance patient care.  Until January ... their ideas and collaborate on solutions through Medstro,s ... Cambridge, MA where they will present ...
Breaking Biology Technology:
... and provides ... content not found elsewhere, MILFORD, Mass., Nov. 3 ... debut of an online community,designed to support the success of ... UltraPerformance,LC(R) (UPLC) System users worldwide, membership in this new online,community ...
... Neb. and GUELPH, Ontario, Nov. 3 ... an agreement to,distribute LI-COR biotechnology products in ... the local presence of Mandel Scientific skilled ... greatly enhance our ability to serve,our Canadian ...
... Albert Liou, Corporate Vice,President and General Manager, Asia-Pacific ... a leading global,biopharmaceutical services provider, will present "What ... Efficiency Savings in Running Clinical,Trials?" at the 7th ... be held November 4 - 7, 2008 at ...
Cached Biology Technology:
(Date:9/28/2015)... , September 28, 2015 The ... to reach USD 12.03 billion by 2020, growing at ... advancements such as Backside Illumination (BSI) technique to improve ... the forecast period.      (Logo: , ... the chip to reduce loss and, thus, reduce the ...
(Date:9/24/2015)... 24, 2015  EyeLock LLC, a market leader of ... winning and latest technology in Booth #602 at next ... . EyeLock,s iris authentication technology provides an ... accuracy, making it the most proven way to authenticate ... technology to deliver a fast and friendly user experience ...
(Date:9/10/2015)... , Sept. 10, 2015 Report Details ... not quite delivered upon previous expectations of revenues, consumer ... the breakthrough year in which wearables begin to achieve ... One of the main reasons is the entrance of ... only the SmartWatches market, but the overall size of ...
Breaking Biology News(10 mins):
... Care through Bio and Information Standards and Technologies, a ... standards can play in helping the United States manage ... technology investments should be made to enhance health care ... WHEN: Tuesday 25 September, 8:30 a.m. to 5:30 ...
... in French . , Vancouver, B.C. - ... Natural Resources will speak at the UBCM Pine Beetle ... under the Mountain Pine Beetle Program to help affected ... Hotel, Mackenzie Room, 900 Canada Place Way, Vancouver, B.C. ...
... counselling on diet and lifestyle offers significant benefits to ... University Technology research. Dietitian Katrina Campbell, who graduated ... 62 pre-dialysis patients at the Royal Brisbane and Women,s ... part of her thesis. Dr Campbell said depending ...
Cached Biology News:
PEG 8000 is used in the precipitation of phage, isolation of plasmid DNA and the enhancement of blunt-ended ligation reactions....
Mouse Iduronate 2-Sulfatase Affinity Purified Polyclonal Ab Keywords: Sulfatases, Iduronate 2-Sulfatase, Mucopolysaccharidosis, Hunter Syndrome, Glycobiology Protein Family: Proteoglycan Regu...
An instrument that delivers an accurate and uniform amount of light energy to cells to photoactivate csiRNA products....
interferon-related developmental regulator 2...
Biology Products: